Mycalolides are trisoxazole macrolides isolated from the marine sponge Mycale sp., which shows cytotoxic, antifungal, and actin-depolymerizing activities. To develop an efficient synthetic route of mycalolides and to evaluate its functional mechanism of biological activities, tris-oxazole macrolactone analogs of mycalolides were synthesized through the use of ringclosing metathesis (RCM). The presence/absence of protecting groups at C3, solvent polarity, and reaction temperature significantly affected the stereoselectivity of RCM (E:Z = 2.5/1.0 to 1.0/2.5). The 19E-and 19Z-stereoisomers both exhibited moderate cytotoxicity against tumor cells, but neither showed significant actin-depolymerizing properties or antimycotic activity against pathogenic fungi. Thus, both the side-chain (actin-binding) moiety and the macrolactone moiety were suggested to be essential for the potent biological activities of the parent molecules.
Introduction
Various actin-depolymerizing agents have been found in marine invertebrates, and some show extremely potent cytotoxicity. They are considered to be useful for the development of novel pharmacological tools for analyzing actinmediated cell functions, such as muscle contraction, cell motility, and cytokinesis. Among them, mycalolide B (1) is a unique trisoxazole macrolide that was isolated from the marine sponge Mycale sp. (Fig. 1 ), 1 which exhibits various biological activities, such as cytotoxicity against B16 melanoma cells, inhibition of actomyosin Mg 2+ -ATPase, 2 and antimycotic activity against several pathogenic fungi. 3 It has been suggested that several antifungal compounds might serve as a chemical defense against microbial attack for marine invertebrates that lack cellular immune systems. 4 Many tris-oxazole macrolides that are structurally related to mycalolides have been isolated, such as ulapualides, 5 halichondramides, 6 jaspisamides, 7 and kabiramides; 8 and all of these exhibit potent actin-depolymerizing properties. X-ray analyses of the actin-kabiramide C, 9 actin-jaspisamide A, 9 and actin-ulapualide A complexes 10 revealed that their side-chain parts (C25-C35) intercalate into the hydrophobic cleft between subdomains 1 and 3 of actin. Furthermore, aplyronine A (4) , which shows potent antitumor activities against several cancers, also possesses an actin-binding side-chain part similar to that of mycalolides. [11] [12] [13] Photoaffinity labeling experiments 14 and X-ray crystallographic analysis 15 have also established that the interactions of actin-aplyronines are closely related to those of mycalolides. Meanwhile, the macrocyclic functional groups of aplyronines, i.e., the C7 trimethylserine and C9 hydroxyl groups, have been shown to be essential for its potent cytotoxicity. 16 Thus, we expected that the structurally unique macrolactone moieties in mycalolides and related tris-oxazole macrolides could serve as a pharmacophore that enable them to specifically interact with biomacromolecules to exhibit various biological activities. Due to their complexity and unique biological activities, there have been several synthetic studies on tris-oxazole macrolides. 17 Recently, total syntheses of mycalolide A 18 and ulapualide A 19 have been described. We previously synthesized the C22-C35 part 2 of mycalolide B, which showed significant actindepolymerizing activity corresponding to that of 1, but no cytotoxicity. 20 However, mycalolide derivatives that consist of the tris-oxazole macrolactone part alone have not yet been synthesized and characterized. It was expected that ulapualides and halichondramide could incorporate several metal ions (i.e. Fe, Co, Cu) to form coordination complexes, in which the oxazole N atoms and the O atoms of C3 and C7 oxygenated functional groups may coordinate to metals. 21 Thus, it is possible that the lactone moiety of mycalolides and related tris-oxazole macrolides might serve as an ionophore, which could contribute to their unique bioactivities. Here we describe the synthesis of tris-oxazole macrolactone analogs 3 through the use of ringclosing metathesis (RCM) along with their biological activities.
Results and discussion

Molecular modeling studies
First, we estimated the three-dimensional structure of the macrolactone part of 1 by using a molecular modeling method. A conformational analysis and density functional theory (DFT) calculation of tris-oxazole macrolactone analogs 3 revealed that the 19E isomer is lower in energy than the 19Z isomer by 5.4 kJ/mol at the B3LYP/6-31G(d) level of theory. (Fig. 2) 22 This difference was almost identical to that for (E)-and (Z)-2-(1butenyl)oxazoles (6.2 kJ/mol). Conjugated tris-oxazoles, the C7 conjugated ketones, and the C19 olefin moieties in both (E)-and (Z)-3 have an almost planar orientation, which suggested that their conformations are considerably fixed. The distances between the C3 hydroxyl H atom and two oxazole N atoms of (E)-3 were less than 3.1 Å, which strongly indicated the presence of intramolecular hydrogen bonding. In contrast, the C3 hydroxyl group in (Z)-3 did not interact with the tris-oxazole moiety. These significant differences in the stereostructures of E-and Zisomers led us to synthesize both isomers and compare their biological activities. 
Synthesis of the tris-oxazole macrolactone analogs of mycalolides
Based on the finding that olefin metathesis is a useful method for connecting the C19-C20 double bonds in mycalolide analogs, 23 we considered that the assembly of two fragments via Ni/Cr-mediated Nozaki-Hiyama-Kishi coupling 24 at C6-C7 and RCM at C19 could efficiently afford 3. The synthesis started with syn-homoallylic alcohol 6, which was prepared from methyl (S)-(+)-3-hydroxy-2-methylpropionate (5) 25 (Scheme 1). Methylation of compound 6 by methyl trifluoromethanesulfonate (MeOTf) (90%) and removal of the tert-butyldiphenylsilyl (TBDPS) group by tetra-n-butylammonium fluoride (TBAF) gave primary alcohol 8 (96%). Hydrolysis of methyl ester in 9 23b with LiOH afforded carboxylic acid 10 (80%), which was condensed with 8 by the Yamaguchi procedure to afford ester 11 in 92% yield. Fragment coupling between 11 and aldehyde 12 23b by a Ni/Cr-mediated reaction (73%) was followed by oxidation of the C7 allylic alcohol with Dess-Martin periodinane (DMP) to afford the RCM precursor 14 (94%). Alternatively, removal of the TBDPS group of 14 by TBAF with acetic acid (AcOH) gave another RCM precursor 15 in 72% yield. With the key intermediates 14 and 15 in hand, RCM reactions were examined (Table 1) . Despite the calculation results that 19E-macrolactone 3 was lower in energy than its 19Z-isomer, treatment of 14 with 30 mol% of 2nd-generation Hoveyda-Grubbs catalyst 26 in refluxing toluene (1 mM) gave tris-oxazole lactone 16 as a separable 1:1.9 mixture of E-and Z-isomers in 61% yield (entry 1). Similarly, the reaction at 40 °C in hexane preferred the Z-isomer (E/Z = 1.0/2.5) (entry 2). 27 With the use of benzotrifluoride as a solvent, 28 the RCM reaction was completed in 1 h, and the yield of the E-isomer was improved (entry 3). Interestingly, the E/Z product ratio was reversed at lower temperature in the same solvent (entry 4) or in ethyl acetate (entry 5). Furthermore, refluxing conditions in dichloromethane gave the best results (82%, E/Z = 1.8/1.0) (entry 6). 29 These results suggested that both the solvent polarity and reaction temperature significantly affected the stereoselectivity of the RCM reaction of 14, and that the formation of C=C bonds in 16 would take place under kinetic control. 23b Table 1 Ring-closing metathesis of 14
Entry
Reaction conditions [a] Yield of 16 (%) Finally, removal of the TBDPS groups of the stereoisomers (E)-and (Z)-16 by TBAF with AcOH afforded trisoxazole macrolactones (E)-and (Z)-3 in respective yields of 87% and 91% (Scheme 2). Scheme 2. Synthesis of tris-oxazole macrolactones 3. Reagents and conditions: (a) TBAF, AcOH, THF, rt, 87% for (E)-3 and 91% for (Z)-3.
For comparison, we also examined the RCM reaction of C3 hydroxyl analog 15 (Scheme 3). While the reaction was slower than that of silyl ether 14 (see Table 1 , entry 6), refluxing conditions in dichloromethane (1 mM) gave macrolactone 3 in 72% yield, and the E-selectivity was slightly improved (E/Z = 2.5/1.0). Thus, it is expected that the RCM precursor 15 would have a specific conformation to prefer the formation of the Eisomer, due to intramolecular hydrogen bonding between the hydroxyl H atom and oxazole N atom(s), which might enable terminal olefins to move toward each other. 
Biological activities
While the E-and Z-stereoisomers of tris-oxazole macrolactone analogs 3 both exhibited moderate cytotoxicity against human epithelial carcinoma HeLa S3 cells, they were approximately 100 times less cytotoxic than mycalolide B (1) ( Table 2 ). Furthermore, they exhibited no significant actin-depolymerizing effects. In addition, neither (E)-nor (Z)-3 exhibited in vitro antimycotic activity against several pathogenic fungi (Aspergillus fumigatus, Candida albicans, and Trichophyton mentagrophytes) or normal fungi (Mucor hiemalis and Rhizopus nigricans) at 30 µg/mL. Thus, both the side-chain and the macrolactone moieties were suggested to be essential for the potent cytotoxicity or antimycotic activity of the parent molecules. 30 Table 2 Biological activities of mycalolide analogs Compound Cytotoxicity (HeLa S3) IC50 (µg/mL) Actin-depolymerizing activity EC50 (µM) [a] Mycalolide B (1) 0.020 1.4 [b] 2 >10 [b] 2.7 [b] 
Conclusions
In conclusion, we concisely synthesized tris-oxazole macrolactone analogs of mycalolides by using Nozaki-Hiyama-Kishi coupling at C6-C7, esterification, and RCM at C19 as key steps. We established that both the side-chain (actin-binding) moiety and the macrolactone moiety were essential for the potent biological activities of the parent molecules. Further studies on the structure-activity relationships for mycalolides and related actin-targeting natural products as well as their mechanisms of action are currently underway.
Experimental Section
General
All chemicals were obtained commercially unless otherwise noted. Organic solvents and reagents for moisture-sensitive reactions were distilled by the standard procedure. Anhydrous CH 2 Cl 2 , tetrahydrofuran (THF), and N,N-dimethylformamide (DMF) were obtained commercially. Column chromatography was performed using silica gel BW-820MH or FL60D (75-200 or 45-75 µm, Fuji Silysia Co., Aichi, Japan) or a Yamazen preparative silica gel (40 µm). All moisture-sensitive reactions were performed under an atmosphere of argon or nitrogen, and the starting materials were azeotropically dried with benzene before use. Merck precoated silica gel 60 F254 plates were used for thin layer chromatography (TLC).
Spectroscopic analysis
1 H and 13 C nuclear magnetic resonance (NMR) spectra were recorded on a Bruker Biospin AVANCE 600 spectrometer (600 MHz for 1 H and 150 MHz for 13 C), or a JEOL EX-270 spectrometer (270 MHz for 1 H). Chemical shifts were reported in parts per million (ppm) with coupling constants (J) in hertz relative to the solvent peaks, d H 7.26 (residual CHCl 3 ) and d C 77.0 for CDCl 3 , respectively. Optical rotations were measured with a JASCO DIP-1000 polarimeter using the sodium D line. Infrared (IR) spectra were recorded on a JASCO FT/IR-230 spectrometer. High-resolution electrospray ionization mass spectra (HR-ESIMS) were measured on a QSTAR Pulsar i spectrometer (Applied Biosystems) or an AccuTOF CS spectrometer (JEOL).
Synthesis and spectroscopic data of mycalolide derivatives
4.3.1. Methyl ether 7. To a stirred solution of (-)-secondary alcohol 6 (787 mg, 2.14 mmol, >99%ee, syn/anti = 93/7) in dry CH 2 Cl 2 (4.8 mL) were added methyl trifluoromethanesulfonate (0.72 mL, 6.4 mmol) and 2,6-di-tert-butylpyridine (1.5 mL, 6.4 mmol) at 0 °C under a nitrogen atmosphere. After being stirred for 20 h at room temperature, the reaction mixture was quenched with sat. sodium bicarbonate aq. (15 mL) at 0 °C, stirred for 45 min at room temperature, and extracted with CH 2 Cl 2 (5 mL ´ 4).
The combined extracts were washed with water and brine, dried with Na 2 SO 4 , and concentrated. The crude material was purified with a Yamazen preparative SiO 2 column (30 g, hexane / EtOAc = 100/0 to 95/5) to give methyl ether 7 (737 mg, 90%, syn/anti = 93/7) as a colorless oil. 7: R f 0.41 (hexane / EtOAc = 9:1); [a] 3009, 2962, 2932, 2859, 1640, 1589, 1472, 1428, 1389, 1362, 1217, 1112, 1088, 998, 918 3632, 3484, 3081, 3009, 2979, 2935, 2832, 1641, 1460, 1428, 1380, 1361, 1236, 1192, 1083, 1032, 918, 780, 773, 726 cm -1 ; HRMS (ESI) m/z 167.1050 (calcd for C 8 H 16 NaO 2 [M+Na] + , D +0.2 mmu).
Carboxylic acid 10.
To a stirred solution of (+)-methyl ester 9 (302 mg, 0.593 mmol, 99%ee, E/Z = 6.7/1) in THF (3 mL) was added 1 M lithium hydroxide aq. (3.6 mL, 3.6 mmol) at 0 °C. After being stirred for 23 h at 40 °C, the reaction mixture was acidified with 1 M HCl aq. (5 mL) and extracted with Et 2 O (5 mL ´ 4). The combined extracts were washed with brine, dried with Na 2 SO 4 , and concentrated. The crude material was purified with a SiO 2 column (10 g, hexane / EtOAc = 9/1 to 5/1) to give carboxylic acid 10 (234 mg, 80%, E/Z = 6.7/1) as a colorless oil. 10: R f 0.42 (hexane / EtOAc = 2:1); [a] D 25 +33.7 (c 1.22, CHCl 3 ); 1 H NMR (270 MHz, CDCl 3 ) d 7. 4H), 6H), 6.38 (dt, J = 14.4, 7.6 Hz, 1H), 5.98 (d, J = 14.4 Hz, 1H), 4.18 (tt, J = 5.9, 5.9 Hz, 1H) , 2.49 (dd, J = 6.7, 6.5 Hz, 2H), 2. 30-2.16 (m, 2H) , 1.06 (s, 9H). COOH signal was not observed; 13 3073, 3054, 3010, 2961, 2933, 2897, 2860, 1712, 1606, 1589, 1472, 1428, 1363, 1221, 1111, 951, 822, 786, 704 4.3.4 . Ester 11. To a stirred solution of carboxylic acid 10 (234 mg, 0.473 mmol) in dry THF (8.6 mL) under a nitrogen atmosphere were added triethylamine (72 µL, 0.52 mmol) and 2,4,6-trichlorobenzoyl chloride (81 µL, 0.52 mmol). After the mixture was stirred for 5 h at room temperature, the precipitate was removed by centrifugation. After the precipitate was washed with dry THF (4 mL), the combined filtrates and washings were concentrated in vacuo and dissolved in dry benzene (11.8 mL). To the activated ester solution was added a solution of primary alcohol 8 (75.3 mg, 0.522 mmol, syn/anti = 93/7) and N,Ndimethyl-4-aminopyridine (124 mg, 1.02 mmol) in dry benzene (4 mL) under a nitrogen atmosphere. After being stirred for 2 h at room temperature, the reaction mixture was quenched with sat. sodium bicarbonate aq. (10 mL), and extracted with EtOAc (3 mL ´ 5). The combined extracts were washed with brine, dried with Na 2 SO 4 , and concentrated. The crude oil was purified with a SiO 2 column (FL60D, 9 g, hexane / EtOAc = 49/1 to 4/1) to give ester 11 (269 mg, 92%, syn/anti = 99/1, E/Z = 6.1/1) as a colorless oil. 11: R f 0.60 (hexane / EtOAc = 5:1); [a] 3074, 3054, 3010, 2962, 2933, 2897, 2860, 2829, 1729, 1641, 1472, 1428, 1363, 1233, 1190, 1105, 998, 952, 920, 822, 735, 704 
Allylic alcohol 13.
To a stirred solution of (-)-aldehyde 12 (23.3 mg, 70.8 µmol) and ester 11 (65.9 mg, 106 µmol, E/Z = 6.1/1) in degassed dry THF / DMF (3:1, 1.3 mL) under an argon atmosphere was added a 99:1 (w/w) mixture of chromium chloride (II) -nickel chloride (II) (56.5 mg, CrCl 2 455 µmol and NiCl 2 4.36 µmol). After being stirred for 14 h, the reaction mixture was diluted with EtOAc (4 mL), sat. ammonium chloride aq. (4 mL), and water (1 mL), and extracted with EtOAc (4 mL ´ 3). The combined extracts were washed with brine, dried with Na 2 SO 4 , and concentrated. The crude oil was purified with a SiO 2 column (3.1 g, hexane / CHCl 3 / EtOAc = 1/1/0, 3/7/0, 0/1/0, 0/4/1 and 0/3/1) to give allylic alcohol 13 (42.7 mg, 73%, 5Eisomer only, ca. 3:2 diastereomer mixture at C7) as a colorless oil. 30 (s, 0.4H), 5H), 6H), 6.67 (dd, J = 17.7, 11.2 Hz, 1H), 6.34 (d, J = 17.7 Hz, 1H), 5.77 (d, J = 11.2 Hz, 1H), 5.74 (m, 1H), 5.55 (m, 1H), 5.39 (m, 1H), 5.08 (d, J = 17.2 Hz, 1H), 5.03 (d, J = 10.2 Hz, 1H), 0.4H), 4.26 (d, J = 7.9 Hz, 0.6H), 0.6H), 4.17 (d, J = 7.8 Hz, 0.4H), 4.01 (m, 1H) , 3.97 (m, 1H), 3.84 (m, 1H), 3.30 (s, 1.2H), 3.30 (s, 1.8H), 3.29 (s, 1.8H), 3.28 (s, 1.2H), 3.16 (m, 1H), 2.51-2.43 (m, 2H), 2.36-2.12 (m, 6H), 1.89 (m, 1H), 1.02 (s, 9H), 0.87 (d, J = 6.8 Hz, 1.2H), 0.86 (d, J = 6.8 Hz, 1.8H), 0.75 (d, J = 7.1 Hz, 1.2H), 0.65 (d, J = 6.9 Hz, 1.8H); 13 C NMR (150 MHz, CDCl 3 ) d 171.34 [171.27], 161.90 [161.89], 156.0, 155.3 [155.0], 141.0 [140.6], 138.96 [138.95], 138.43 [138.39], 136.7 [136.5], 135.8 (4C), 134.9 [134.8], 134.3, 134.0 [133.9], 133.7 (2C), 131.54 [131.50], 130.7, 129.7 [129.6], 127.8, 127.5 (4C), 126.4 [124.2], 122.5, 117.0, 80.9, 80.1 [79.9], 75.7 [73.0], 70.2 [70.1], 66.6, 58.0 [57.5], 57.2 [56.9], 42.5, 42.1, 41.5 [41.4], 40.0, 39.8, 35.3, 26.9, 19.2, 12.0, 11.4, 11.02 [11.01] (sprit signals derived from the C7 diastereomer were shown in parenthesis); IR (CHCl 3 ) 3673, 3462, 3167, 3072, 3029, 3009, 2966, 2933, 2899, 2859, 2828, 1729, 1651, 1542, 1462, 1428, 1380, 1308, 1238, 1218, 1191, 1111, 980, 942, 918, 822 3163, 3027, 3010, 2933, 2859, 1729, 1694, 1665, 1637, 1542, 1462, 1428, 1376, 1308, 1111, 978, 943, 919, 823, 703 (22.7 mg, 27.6 µmol) in THF (10.2 mL) under a nitrogen atmosphere at 0 °C were added a 1 M solution of tetra-nbutylammonium fluoride in THF (0.86 mL, 0.86 mmol) and acetic acid (49 µL). After being stirred for 18 h at room temperature, the reaction mixture was diluted with sat. sodium bicarbonate aq. (10 mL) and extracted with EtOAc (5 mL ´ 4). The combined extracts were washed with brine, dried with Na 2 SO 4 , and concentrated. The crude oil was purified with SiO 2 columns (FL60D 1.2 g, CHCl 3 / EtOAc = 4/1 to 1/1; FL60D 0.4 g, EtOAc) to give secondary alcohol 15 (11.6 mg, 72%) as a colorless oil. 15: R f 0.66 (CHCl 3 / MeOH = 10:1); [a] 
Bioassay of mycalolide B and its synthetic analogs
The cytotoxicities of the probes and model compounds were measured by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5diphenyltetrazolium bromide) method. 19a The actindepolymerizing activities of the compounds were measured based on their ability to attenuate the fluorescence of pyreneconjugated (pyrenyl) actin, as previously described. 12a Antimycotic assays against several fungi were conducted at Ricerca Biosciences Inc. (Taipei, Taiwan).
